Related Experiment Video
Updated: Mar 17, 2026
Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion
Published on: April 19, 2024
Concussions, Traumatic Brain Injury, and the Innovative Use of Omega-3s
1a Brain Health Education and Research Institute , Potomac , Maryland.
Abstract:
Traumatic brain injury (TBI), with its diverse heterogeneity and prolonged secondary pathogenesis, remains a clinical challenge. Clinical studies thus far have failed to identify an effective treatment strategy when a combination of targets controlling aspects of neuroprotection, neuroinflammation, and neuroregeneration is needed. Omega-3 fatty acids (n-3FA) offer the advantage of this approach. Although further clinical trial research is needed, there is a growing body of strong preclinical evidence and clinical experience that suggests that benefits may be possible from aggressively adding substantial amounts of n-3FA to optimize the nutritional foundation of TBI, concussion, and postconcussion syndrome patients. Early and optimal doses of n-3FA, even in a prophylactic setting, have the potential to improve outcomes from this potentially devastating problem. With evidence of unsurpassed safety and tolerability, n-3FA should be considered mainstream, conventional medicine, if conventional medicine can overcome its inherent bias against nutritional, nonpharmacologic therapies.
Insights
Omega-3 fatty acids (n-3FA) show promise for treating traumatic brain injury (TBI) and related conditions. Aggressively supplementing n-3FA may improve outcomes by supporting neuroprotection, neuroinflammation, and neuroregeneration.
Area of Science:
- Neuroscience
- Nutritional Science
Background:
- Traumatic brain injury (TBI) presents a significant clinical challenge due to its heterogeneity and complex secondary pathogenesis.
- Current treatment strategies often fail to address the multifaceted needs of TBI patients, including neuroprotection, neuroinflammation, and neuroregeneration.
Purpose of the Study:
- To evaluate the potential of omega-3 fatty acids (n-3FA) as a therapeutic approach for TBI, concussion, and postconcussion syndrome.
- To highlight the need for further clinical research into n-3FA supplementation for TBI management.
Main Methods:
- Review of preclinical evidence and clinical experience regarding n-3FA in TBI.
- Assessment of the safety and tolerability profile of n-3FA.
Main Results:
- Strong preclinical and clinical evidence suggests n-3FA can support neuroprotection, neuroinflammation, and neuroregeneration.
- Early and optimal n-3FA supplementation, even prophylactically, may improve outcomes in TBI patients.
Conclusions:
- Omega-3 fatty acids offer a promising, safe, and well-tolerated nutritional strategy for optimizing TBI patient care.
- Conventional medicine should consider n-3FA as a mainstream therapy, overcoming potential biases against non-pharmacologic interventions.
